Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple PodcastsSpotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Podcast Format

 
 
 
Recent advancements in treatment and a multimodal approach to care are improving outcomes for patients with head and neck cancer, however access to therapies and unique patient challenges due to disease symptoms, difficulty eating, difficulty communicating, and other psychosocial factors can reduce patient quality of life.
Founded in 2019, this inclusive lab is comprised of 42 members ranging from undergraduates to faculty from 12 different countries, most of whom self-identify as women and/or individuals who are under-represented in medicine.
In this podcast, Joy Larsen Haidle, Genetic Counselor at North Memorial Health Cancer Center in Robbinsdale, Minnesota, and Lillie Shockney, University Distinguished Service Professor of Breast Cancer, Professor of Surgery at Johns Hopkins University School of Medicine in Baltimore, Maryland, delve into the topic of BRCA mutation testing within breast cancer care, highlighting care gaps and opportunities …
In this podcast, Mila Felder, MD, FACEP, teases her keynote at the ACCC 50th Annual Meeting & Cancer Center Business Summit, why it’s important to attend this session in person, and what she’s looking forward to most at the meeting.
CANCER BUZZ spoke to Robin Atkins, RN, OCN, symptom triage nurse, Virginia Oncology Associates in Norfolk, Virginia. Listen as we discuss effective practices to support patients with diffuse large b-cell lymphoma throughout the care continuum.
As the use of chimeric antigen receptor (CAR) T-cell therapy continues to expand as an effective treatment for hematologic malignancies, understanding how to identify eligible patients early and implementation of an effective framework for identification can improve care coordination and better prepare community cancer programs for widespread use of CAR T-cell therapy.
The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises. Many cancer programs are also facing significant challenges with patient access.
Health technology performance and integration of electronic health record (EHR) systems have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide.. Listen in as CancerBuzz speaks to Karen Huelsman, MS, LGC, precision oncology lead and genetic counselor at TriHealth Cancer and Blood Institute, about key takeaways and insights from the Working …
In 2020, this community-based cancer program started laying the foundation for a disease-site specific oncology patient navigation program that would grow exponentially over the next 2 years.
CANCER BUZZ spoke to Melissa Frey, MD, MS, and Leigha Senter, MS, CGC to discuss germline and somatic testing for patients with ovarian cancer.
Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia.
Hear about the evolution of artificial intelligence in precision oncology and the clinical impact of tech-based solutions.
CANCER BUZZ interviews Karline Paul, Associate Operating Officer at Vanderbilt University Medical Center, about the ways technology can support—not replace—the oncology workforce.
ACCC was invited to share the association’s key priorities for impacting cancer care in the US. ACCC president Olalekan Ajayi, PharmD, MBA, and chief operating officer at Highlands Oncology Group, PA, discusses the meeting and these initiatives.
Live this week from the ACCC 40th National Oncology Conference (NOC), CANCER BUZZ interviews Debbie Rimmele, Nurse Retention Specialist at the Loyola University Medical Center, about recruiting strategies and her session at the NOC: Looking Under the Hood of the Employment Process.
Live this week from the ACCC 40th National Oncology Conference (NOC), CANCER BUZZ interviews Steve Kennedy, Senior Vice President of Human Resources at Tennessee Oncology, about his session: Leadership Engagement and Sustainment During Challenging Times.
Live this week from the ACCC 40th National Oncology Conference, CANCER BUZZ interviews Dr. Michael Gieske about best practices to increase lung cancer screenings and ACCC’s Rural Appalachian Lung Screening Initiative.
CANCER BUZZ previews the sessions, people and topics of this week’s ACCC 40th National Oncology Conference. We interview Kathy Oubre, MS, CEO of the Pontchartrain Canter Center, about helping patients overcome access barriers to biomarker testing.
Hear Dr. Margaret Liang, of Cedars-Sinai Cancer Center, Los Angeles, talk about ACCC’s Financial Advocacy Network (FAN) and the Financial Advocacy Services guidelines to help cancer programs address the growing issue of financial toxicity.
Disparities in bladder cancer care persist, especially with respect to race. In fact, patient demographics has a proven impact on health outcomes. Listen in as CancerBuzz speaks to Mary W. Dunn, MSN, RN, OCN, NP-C, Adult Nurse Practitioner of Urology and Medical Oncology at the UNC Lineberger Comprehensive Cancer Center and Samuel L. Washington III, MD, MAS, Assistant Professor of Urology at the University …
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.